Comparison between calcium channel blocker with angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker combination on the development of new-onset diabetes in hypertensive Korean patients

被引：0
|
作者：
Yong Hoon Kim
Ae-Young Her
Seung-Woon Rha
Byoung Geol Choi
Se Yeon Choi
Jae Kyeong Byun
Dong Oh Kang
Won Young Jang
Woohyeun Kim
Ju Yeol Baek
Woong Gil Choi
Tae Soo Kang
Jihun Ahn
Sang-Ho Park
Sung Hun Park
Ji Yeon Hong
Ji Young Park
Min-Ho Lee
Cheol Ung Choi
Chang Gyu Park
Hong Seog Seo
机构：
[1] Kangwon National University School of Medicine,Department of Internal Medicine, Division of Cardiology
[2] Korea University Guro Hospital,Cardiovascular Center
[3] Korea University Graduate School,Department of Medicine
[4] Seoul St. Mary’s Hospital,Cardiovascular Center
[5] the Catholic University of Korea,Cardiology Department
[6] Konkuk University Chungju Hospital,Department of Internal Medicine, Cardiovascular Division
[7] Dankook University Hospital,Department of Cardiology
[8] Soonchunhyang University Gumi Hospital,Cardiology Department
[9] Soonchunhyang University Cheonan Hospital,Department of Internal Medicine, Division of Cardiology, Cardiovascular Center, Nowon Eulji Medical Center
[10] Eulji University,Department of Cardiology
[11] Soonchunhyang University College of Medicine,undefined
来源：
Journal of Diabetes & Metabolic Disorders | 2020年 / 19卷
关键词：
Angiotensin converting enzyme inhibitor; Angiotensin II type 1 receptor blocker; Calcium channel blocker; Diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：405 / 413
页数：8
相关论文
共 50 条
  • [21] Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor
    Sleight, Peter
    JOURNAL OF HYPERTENSION, 2009, 27 : S23 - S29
  • [22] Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: A review and pooled analysis
    McCall, Kenneth L.
    Craddock, Deeatra
    Edwards, Krystal
    PHARMACOTHERAPY, 2006, 26 (09): : 1297 - 1306
  • [23] Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin h receptor blocker therapy in heart failure
    Yasumura, Y
    Miyatake, K
    Okamoto, H
    Miyauchi, T
    Kawana, M
    Tsutamoto, T
    Kitakaze, M
    Matsubara, H
    Takaoka, H
    Anzai, T
    Himeno, H
    Yokoyama, H
    Yokoya, K
    Shintani, U
    Hashimoto, K
    Koretsune, Y
    Nakamura, Y
    Imai, K
    Maruyama, S
    Masaoka, Y
    Sekiya, M
    Shiraki, T
    Shinohara, H
    Ozono, K
    Matsuoka, T
    Miyao, Y
    Nomura, F
    CIRCULATION JOURNAL, 2004, 68 (04) : 361 - 366
  • [24] Lack of effect on coronary atherosclerotic disease biomarkers with modest dosing of an angiotensin-converting enzyme inhibitor, angiotensin II type-1 receptor blocker, and the combination
    Tsikouris, James P.
    Cox, Craig D.
    Simoni, Jan S.
    Seifert, Charles F.
    Peek, Miranda C.
    Meyerrose, Gary E.
    CORONARY ARTERY DISEASE, 2006, 17 (05) : 439 - 445
  • [25] Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT1-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension
    Swales, P
    Williams, B
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2002, 3 (02) : 79 - 89
  • [26] Renoprotective effects of benidipine in combination with angiotensin II type 1 receptor blocker in hypertensive Dahl rats
    Yao, K
    Sato, H
    Ina, Y
    Suzuki, K
    Ohno, T
    Shirakura, S
    HYPERTENSION RESEARCH, 2003, 26 (08) : 635 - 641
  • [27] Comparison of Health Costs Associated with Treatment of Hypertension with a Calcium Channel Blocker and Angiotensin-Converting Enzyme Inhibitor in the United States and Japan
    Yusuke Sakamaki
    Hiroyuki Sasamura
    Shunya Ikeda
    Naoki Ikegami
    Takao Saruta
    Hypertension Research, 2006, 29 : 333 - 338
  • [28] Cardiorenal protective effects of year-long anti hypertensive therapy with a angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats
    Ishimitsu, Toshihiko
    Honda, Takeaki
    Ohta, Satoshi
    Akashiba, Akira
    Takahashi, Toshiaki
    Kameda, Tomoko
    Yoshii, Masayoshi
    Minami, Junichi
    Takahashi, Masaki
    Ono, Hidehiko
    Matsuoka, Hiroaki
    AMERICAN JOURNAL OF HYPERTENSION, 2006, 19 (12) : 1233 - 1240
  • [29] Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan
    Sakamaki, Yusuke
    Sasamura, Hiroyuki
    Ikeda, Shunya
    HYPERTENSION RESEARCH, 2006, 29 (05) : 333 - 338
  • [30] Effect of angiotensin II type 1 receptor blocker and angiotensin converting enzyme inhibitor on the intraocular growth factors and their receptors in streptozotocin-induced diabetic rats
    Byon, Ik Soo
    Lee, Dong Hyun
    Jun, Eun Sook
    Shin, Min Kyu
    Park, Sung Who
    Lee, Ji Eun
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (06) : 896 - 901
12345